NEIL Bajpayee
Nessuna posizione attualmente
Storia della carriera di NEIL Bajpayee
Precedenti posizioni note di NEIL Bajpayee
Società | Posizione | Inizio | Fine |
---|---|---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Investitore di Private Equity | 01/04/2018 | 30/10/2020 |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Direttore/Membro del Consiglio | 01/05/2019 | 30/10/2020 |
Formazione di NEIL Bajpayee
The Pennsylvania State University | Undergraduate Degree |
University of California | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Undergraduate Degree | 1 |
Private Equity Investor | 1 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Finance |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- NEIL Bajpayee
- Esperienza